Breaking News

Monday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
DSM price target raised to EUR 128 from EUR 115.50 at JPMorgan » 13:59
06/29/20
06/29
13:59
06/29/20
13:59
RDSMY

DSM

$0.00 /

+ (+0.00%)

JPMorgan analyst Chetan…

JPMorgan analyst Chetan Udeshi raised the firm's price target on DSM to EUR 128 from EUR 115.50 and keeps an Overweight rating on the shares. The analyst called the stock a Top Idea ahead of the company's Q2 earnings report.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

05/13/20 JPMorgan
DSM price target raised to EUR 115 from EUR 113.50 at JPMorgan
04/29/20 ING Bank
DSM downgraded to Sell from Hold at ING Group
04/15/20 JPMorgan
DSM price target raised to EUR 113.50 from EUR 110 at JPMorgan
03/30/20 Morgan Stanley
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley
Over a month ago
Recommendations
DSM price target raised to EUR 115 from EUR 113.50 at JPMorgan » 10:37
05/13/20
05/13
10:37
05/13/20
10:37
RDSMY

DSM

$0.00 /

+ (+0.00%)

JPMorgan analyst Chetan…

JPMorgan analyst Chetan Udeshi raised the firm's price target on DSM to EUR 115 from EUR 113.50 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

04/29/20 ING Bank
DSM downgraded to Sell from Hold at ING Group
04/15/20 JPMorgan
DSM price target raised to EUR 113.50 from EUR 110 at JPMorgan
03/30/20 Morgan Stanley
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley
03/24/20 JPMorgan
DSM price target lowered to EUR 110 from EUR 125 at JPMorgan
Downgrade
DSM downgraded to Sell from Hold at ING Group » 05:19
04/29/20
04/29
05:19
04/29/20
05:19
RDSMY

DSM

$0.00 /

+ (+0.00%)

ING Group analyst…

ING Group analyst Reginald Watson downgraded DSM to Sell from Hold with a EUR 90.94 price target.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

04/15/20 JPMorgan
DSM price target raised to EUR 113.50 from EUR 110 at JPMorgan
03/30/20 Morgan Stanley
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley
03/24/20 JPMorgan
DSM price target lowered to EUR 110 from EUR 125 at JPMorgan
11/27/19 Bernstein
DSM downgraded to Underperform from Market Perform at Bernstein
Recommendations
DSM price target raised to EUR 113.50 from EUR 110 at JPMorgan » 14:27
04/15/20
04/15
14:27
04/15/20
14:27
RDSMY

DSM

$0.00 /

+ (+0.00%)

JPMorgan analyst Chetan…

JPMorgan analyst Chetan Udeshi raised the firm's price target on DSM to EUR 113.50 from EUR 110 and keeps an Overweight rating on the shares. The analyst called the stock a Top Idea.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

03/30/20 Morgan Stanley
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley
03/24/20 JPMorgan
DSM price target lowered to EUR 110 from EUR 125 at JPMorgan
11/27/19 Bernstein
DSM downgraded to Underperform from Market Perform at Bernstein
09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
Over a quarter ago
Recommendations
DSM price target lowered to EUR 95 from EUR 104 at Morgan Stanley » 13:21
03/30/20
03/30
13:21
03/30/20
13:21
RDSMY

DSM

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Alexandra Thrum lowered the firm's price target on DSM to EUR 95 from EUR 104 and keeps an Equal Weight rating on the shares.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

03/24/20 JPMorgan
DSM price target lowered to EUR 110 from EUR 125 at JPMorgan
11/27/19 Bernstein
DSM downgraded to Underperform from Market Perform at Bernstein
09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
Recommendations
DSM price target lowered to EUR 110 from EUR 125 at JPMorgan » 12:23
03/24/20
03/24
12:23
03/24/20
12:23
RDSMY

DSM

$0.00 /

+ (+0.00%)

JPMorgan analyst Chetan…

JPMorgan analyst Chetan Udeshi lowered the firm's price target on DSM to EUR 110 from EUR 125 and keeps an Overweight rating on the shares.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

11/27/19 Bernstein
DSM downgraded to Underperform from Market Perform at Bernstein
09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
07/05/19 JPMorgan
DSM upgraded to Overweight from Neutral at JPMorgan
Downgrade
DSM downgraded to Underperform from Market Perform at Bernstein » 05:41
11/27/19
11/27
05:41
11/27/19
05:41
RDSMY

DSM

$0.00 /

+ (+0.00%)

Bernstein downgraded DSM…

Bernstein downgraded DSM to Underperform from Market Perform with a EUR 93 price target.

ShowHide Related Items >><<
RDSMY DSM
$0.00 /

+ (+0.00%)

09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
07/05/19 JPMorgan
DSM upgraded to Overweight from Neutral at JPMorgan
02/01/19 Goldman Sachs
DSM upgraded to Buy from Neutral at Goldman Sachs
Periodicals
DSM said to explore bid for DuPont nutrition unit, Bloomberg says » 10:04
09/16/19
09/16
10:04
09/16/19
10:04
DD

DuPont

$72.88 /

-0.65 (-0.88%)

, RDSMY

DSM

$0.00 /

+ (+0.00%)

DSM is said to be among…

DSM is said to be among the suitors for the DuPont unit, which could be valued at as much as $25B, Bloomberg reported.

ShowHide Related Items >><<
DD DuPont
$72.88 /

-0.65 (-0.88%)

09/10/19
Fly Intel: Top five analyst initiations
09/10/19 Jefferies
DuPont initiated with a Buy at Jefferies
09/10/19 Citi
DuPont management 'seems relentless' in driving value, shares Citi
09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
RDSMY DSM
$0.00 /

+ (+0.00%)

09/04/19 Morgan Stanley
Morgan Stanley says new round of chemical industry consolidation may be coming
08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
07/05/19 JPMorgan
DSM upgraded to Overweight from Neutral at JPMorgan
02/01/19 Goldman Sachs
DSM upgraded to Buy from Neutral at Goldman Sachs
Recommendations
Morgan Stanley says new round of chemical industry consolidation may be coming » 08:02
09/04/19
09/04
08:02
09/04/19
08:02
DD

DuPont

$67.41 /

-0.49 (-0.72%)

, CE

Celanese

$111.61 /

-1.88 (-1.66%)

, RDSMY

DSM

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Morgan Stanley analyst Vincent Andrews notes that DuPont (DD) can pursue further tax-free strategic options as of September 1, which was the two-year anniversary of the DowDuPont merger, and he also notes that DuPont and Celanese (CE) executives have made public comments about strategic alternatives being a clear priority. Andrews, who thinks "converging forces" may create the environment for a new round of chemical industry consolidation and other dealmaking, believes Celanese, DuPont and DSM (RDSMY) could "be the nexus of any activity" given their size, resources and management commentary. Citing his view that the market will increasingly price in potential M&A, Andrews increased his price target on DuPont shares to $85 from $78, raised his Celanese target to $124 from $102 and upped his DSM target to EUR104 from EUR90. He recommends DuPont as the best way to play the chemical consolidation theme and keeps an Overweight rating on the shares, while keeping Equal Weight ratings on the other two stocks named above.

ShowHide Related Items >><<
DD DuPont
$67.41 /

-0.49 (-0.72%)

08/30/19
Fly Intel: Top five analyst upgrades
08/30/19 Exane BNP Paribas
DuPont upgraded to Outperform from Neutral at Exane BNP Paribas
08/07/19 BMO Capital
DuPont price target lowered to $85 from $95 at BMO Capital
07/05/19 Loop Capital
Corteva may be on the hook for legacy DuPont liabilities, says Loop Capital
CE Celanese
$111.61 /

-1.88 (-1.66%)

07/24/19
Fly Intel: Top five analyst upgrades
07/24/19 JPMorgan
JPMorgan upgrades Celanese to Overweight on 'surprisingly durable' results
07/24/19 JPMorgan
Celanese upgraded to Overweight from Neutral at JPMorgan
07/23/19 Baird
Celanese EM volume decline could impact sentiment, says Baird
RDSMY DSM
$0.00 /

+ (+0.00%)

08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
07/05/19 JPMorgan
DSM upgraded to Overweight from Neutral at JPMorgan
02/01/19 Goldman Sachs
DSM upgraded to Buy from Neutral at Goldman Sachs
On The Fly
Fly Intel: Wall Street's top stories for Tuesday » 17:42
08/06/19
08/06
17:42
08/06/19
17:42
TTWO

Take-Two

$124.56 /

+9.19 (+7.97%)

, IFF

IFF

$118.88 /

-22.57 (-15.96%)

, MCK

McKesson

$138.99 /

-5.67 (-3.92%)

, CAH

Cardinal Health

$42.91 /

-2.64 (-5.80%)

, ABCR

ABC Rail Products

$0.00 /

+ (+0.00%)

, NVS

Novartis

$88.16 /

-2.57 (-2.83%)

, BIIB

Biogen

$240.13 /

+4.98 (+2.12%)

, IONS

Ionis Pharmaceuticals

$64.06 /

+2.02 (+3.26%)

, DD

DuPont

$68.55 /

+2.5 (+3.79%)

, RDSMY

DSM

$0.00 /

+ (+0.00%)

, ZAGG

Zagg

$6.92 /

+0.88 (+14.57%)

, EVER

EverQuote

$19.70 /

+6.35 (+47.57%)

, SHAK

Shake Shack

$86.63 /

+13.07 (+17.77%)

, CRCM

Care.com

$7.72 /

-2.515 (-24.58%)

, GSKY

GreenSky

$6.81 /

-3.62 (-34.71%)

, AVID

Avid Technology

$6.12 /

-3.54 (-36.65%)

Stocks recovered some of…

Open Full Text

ShowHide Related Items >><<
TTWO Take-Two
$124.56 /

+9.19 (+7.97%)

08/06/19 Wedbush
Take-Two price target raised to $144 from $134 at Wedbush
08/06/19 Credit Suisse
Take-Two price target raised to $125 from $118 at Credit Suisse
08/06/19 Jefferies
Take-Two price target raised to $125 from $115 at Jefferies
08/06/19 KeyBanc
Take-Two price target raised to $150 from $145 at KeyBanc
IFF IFF
$118.88 /

-22.57 (-15.96%)

06/21/19 Exane BNP Paribas
International Flavors downgraded to Underperform at Exane BNP Paribas
06/07/19 KeyBanc
International Flavors price target raised to $160 from $143 at KeyBanc
03/21/19 Goldman Sachs
Goldman upgrades International Flavors to Buy on 'compelling entry point'
03/20/19 Goldman Sachs
International Flavors upgraded to Buy from Neutral at Goldman Sachs
MCK McKesson
$138.99 /

-5.67 (-3.92%)

08/06/19 Cleveland Research
Cardinal Health recently lost 2 major accounts, says Cleveland Research
08/05/19 Wolfe Research
McKesson downgraded to Peer Perform from Outperform at Wolfe Research
07/22/19 Credit Suisse
McKesson reinstated with a Neutral at Credit Suisse
07/22/19 Guggenheim
McKesson initiated with a Neutral at Guggenheim
CAH Cardinal Health
$42.91 /

-2.64 (-5.80%)

07/11/19 Raymond James
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
04/17/19 Guggenheim
Cardinal Health initiated with a Neutral at Guggenheim
04/17/19 Guggenheim
Cardinal Health initiated with a Neutral at Guggenheim
ABCR ABC Rail Products
$0.00 /

+ (+0.00%)

NVS Novartis
$88.16 /

-2.57 (-2.83%)

07/26/19 Canaccord
Homology Medicines selloff yesterday a buying opportunity, says Canaccord
07/23/19 B. Riley FBR
B. Riley FBR upgrades Adamis to Neutral, keeps $1.10 price target
07/23/19 Argus
Novartis price target raised to $105 from $92 at Argus
07/23/19
Novartis downgraded to Hold from Buy at Kepler Cheuvreux
BIIB Biogen
$240.13 /

+4.98 (+2.12%)

07/30/19 Piper Sandler
Piper says Alkermes scores 'back-to-back wins' with settlement, Biogen data
07/30/19 Piper Sandler
Biogen investors may be disappointed by Vumerity update, says Piper Jaffray
07/30/19 JPMorgan
Alkermes, Biogen data a positive, but questions remain, says JPMorgan
07/26/19 Piper Sandler
AbbVie trial discontinuation adds risk to Biogen pipeline, says Piper Jaffray
IONS Ionis Pharmaceuticals
$64.06 /

+2.02 (+3.26%)

07/23/19 JPMorgan
Competition questions for Biogen, Ions' Spinraza not dissipating soon, says JPMorgan
05/24/19 Piper Sandler
Piper 'incrementally more positive' on Ionis after management meetings
05/09/19 Piper Sandler
Ionis Pharmaceuticals shares 'more interesting on pullback', says Piper Jaffray
05/07/19 Morgan Stanley
Biogen could rise, or fall, 5% based on Zolgensma label, says Morgan Stanley
DD DuPont
$68.55 /

+2.5 (+3.79%)

07/05/19 Loop Capital
Corteva may be on the hook for legacy DuPont liabilities, says Loop Capital
06/25/19 Argus
DuPont should realize $1.1B of merger cost synergies by 2020E, says Argus
06/20/19 RBC Capital
DuPont initiated with a Sector Perform at RBC Capital
06/12/19 Deutsche Bank
DuPont price target raised to $88 from $80 at Deutsche Bank
RDSMY DSM
$0.00 /

+ (+0.00%)

08/05/19 ABN Amro
DSM downgraded to Hold from Buy at ABN Amro
07/05/19 JPMorgan
DSM upgraded to Overweight from Neutral at JPMorgan
02/01/19 Goldman Sachs
DSM upgraded to Buy from Neutral at Goldman Sachs
ZAGG Zagg
$6.92 /

+0.88 (+14.57%)

03/13/19 DA Davidson
Zagg shares still attractively valued, says DA Davidson
09/24/18 DA Davidson
Zagg to benefit from iPhone shield protector demand, says DA Davidson
09/13/18 DA Davidson
Apple new product lineup increases near term sales confidence, says DA Davidson
EVER EverQuote
$19.70 /

+6.35 (+47.57%)

08/06/19
Fly Intel: Top five analyst upgrades
08/06/19 Needham
EverQuote price target raised to $20 from $13 at Needham
08/06/19 Raymond James
EverQuote upgraded to Outperform on 'strong' results, says Raymond James
08/06/19 Oppenheimer
EverQuote price target raised to $19 from $13 at Oppenheimer
SHAK Shake Shack
$86.63 /

+13.07 (+17.77%)

08/06/19 Wedbush
Shake Shack price target raised to $75 from $70 at Wedbush
08/06/19 Credit Suisse
Shake Shack price target raised to $83 from $77 at Credit Suisse
08/06/19 SunTrust
Shake Shack price target raised to $86 from $70 at SunTrust
08/06/19 Barclays
Shake Shack price target raised to $70 from $58 at Barclays
CRCM Care.com
$7.72 /

-2.515 (-24.58%)

08/06/19 Roth Capital
Care.com downgraded to Neutral on continued uncertainty at Roth Capital
08/06/19 Roth Capital
Care.com downgraded to Neutral from Buy at Roth Capital
07/24/19 Roth Capital
Roth Capital still likes Care.com risk/reward despite reduced price target
06/26/19
Care.com downgraded to Hold following CFO transition at Craig-Hallum
GSKY GreenSky
$6.81 /

-3.62 (-34.71%)

08/06/19 Sandler O'Neill
GreenSky downgraded to Hold from Buy at Sandler O'Neill
07/01/19 SunTrust
GreenSky downgraded to Hold from Buy at SunTrust
07/01/19 SunTrust
GreenSky downgraded to Hold from Buy at SunTrust
05/15/19 SunTrust
Green Sky's loss of Regions as funding partner 'not material,' says SunTrust
AVID Avid Technology
$6.12 /

-3.54 (-36.65%)

06/07/19 Jefferies
Avid Technology price target raised to $8.50 from $6.50 at Jefferies
05/01/19
Fly Intel: Top five analyst initiations
05/01/19 Maxim
Avid Technology initiated with a Buy at Maxim
03/21/19 BWS Financial
BWS Financial downgrades Avid to Sell from Hold following recent rally

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.